Skip to main content
Full access
New Research
Published Online: 1 January 2012

Behavioral Health Insurance Parity: Does Oregon's Experience Presage the National Experience With the Mental Health Parity and Addiction Equity Act?

This article has been corrected.
VIEW CORRECTION

Abstract

Expenses for mental illness and substance abuse treatment increased only slightly after implementation of Oregon's law requiring parity between insurance coverage for these disorders and coverage for other conditions. Management of behavioral health benefits through nonquantitative treatment limitations, such as documentation of medical necessity, prior authorization, and utilization review, was allowed but had to conform with restrictions on medical-surgical coverage. This similarity to the federal parity law implemented in 2009 suggests that the new federal requirement of insurance parity will not “break the bank.”

Abstract

Objective:

The Mental Health Parity and Addiction Equity Act of 2008 prohibits commercial group health plans from imposing spending and visit limitations for mental health and substance abuse services that are not imposed on medical-surgical services. The act also restricts the use of managed care tools that apply to behavioral health benefits in ways that differ from how they apply to medical-surgical benefits. The only precedent for this approach is Oregon's state parity law, which was implemented in 2007. The goal of this study was to estimate the effect of Oregon's parity law on expenditures for mental health and substance abuse treatment services.

Method:

The authors compared expenditures for commercially insured individuals in four Oregon health plans from 2005 through 2008 and a matched group of commercially insured individuals in Oregon who were exempt from parity. Using a difference-in-differences analysis, the authors analyzed the effect of comprehensive parity on spending for mental health and substance abuse services.

Results:

Increases in spending on mental health and substance abuse services after implementation of Oregon's parity law were almost entirely the result of a general trend observed among individuals with and without parity. Expenditures per enrollee for mental health and substance abuse services attributable to parity were positive, but they did not differ significantly from zero in any of the four plans.

Conclusions:

Behavioral health insurance parity rules that place restrictions on how plans manage mental health and substance abuse services can improve insurance protections without substantial increases in total costs.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 31 - 38
PubMed: 21890792

History

Received: 24 February 2011
Revision received: 2 May 2011
Revision received: 20 June 2011
Accepted: 24 June 2011
Published online: 1 January 2012
Published in print: January 2012

Authors

Details

K. John McConnell, Ph.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Samuel H.N. Gast, B.A.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
M. Susan Ridgely, J.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Neal Wallace, Ph.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Natalie Jacuzzi, M.P.H.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Traci Rieckmann, Ph.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Bentson H. McFarland, M.D., Ph.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.
Dennis McCarty, Ph.D.
From Oregon Health and Science University, RAND Corporation, and Portland State University.

Notes

Address correspondence to Dr. McConnell ([email protected]).

Funding Information

Dr. McCarty is a Principal Investigator on awards from National Institute on Drug Abuse, a Principal Investigator on awards from the Robert Wood Johnson Foundation, and a member of a study advisory panel with support from Purdue Pharma. Dr. McConnell, Mr. Gast, Ms. Ridgely, and Drs. Wallace, Jacuzzi, Rieckmann, and McFarland report no financial relationships with commercial interests.Funded by National Institute on Drug Abuse grant R01DA024024.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share